Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Prepaid Assets (2019 - 2025)

Keros Therapeutics' Prepaid Assets history spans 7 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 90.86% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, down 90.86%, while the annual FY2025 figure was $2.4 million, 90.86% down from the prior year.
  • Prepaid Assets reached $2.4 million in Q4 2025 per KROS's latest filing, down from $22.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $26.8 million in Q2 2024 to a low of $210000.0 in Q4 2021.
  • Average Prepaid Assets over 5 years is $9.8 million, with a median of $6.7 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: soared 4200.0% in 2023, then crashed 90.86% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $210000.0 in 2021, then skyrocketed by 3099.52% to $6.7 million in 2022, then skyrocketed by 138.18% to $16.0 million in 2023, then soared by 63.84% to $26.2 million in 2024, then plummeted by 90.86% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for KROS's Prepaid Assets are $2.4 million (Q4 2025), $22.3 million (Q3 2025), and $2.5 million (Q2 2025).